Payer Coverage & Health Technology Assessment (HTA) Prompt

Prompt

You are a health economics manager submitting RWE for payer coverage and HTA bodies. Given [PASTE: RWE results on effectiveness, cost-effectiveness, patient experience, and comparable therapies], develop payer submission:

1. Present real-world effectiveness data (treatment response, durability of response, clinical outcomes)
2. Calculate cost-effectiveness (cost per unit of outcome, comparison to ICER thresholds, budget impact)
3. Summarize patient impact (quality of life, treatment burden, healthcare utilization reduction)
4. Compare to clinical trial efficacy (RWE consistency or divergence, explanation)
5. Address payer questions (generalizability, evidence quality, comparator selection)

Output: payer evidence briefing (RWE effectiveness summary | cost-effectiveness analysis | patient impact | budget impact model | strength of evidence assessment | coverage recommendation support).

Why it works

RWE supports payer value arguments and coverage negotiation.

Watch out for

Payers are skeptical of RWE if less robust than RCTs. Budget impact models are sensitive to utilization and pricing assumptions.

Used by

Data AnalystsFinance Teams

Browse all prompts →